JW Pharmaceutical Corp (001060) Stock Price & News

Why is 001060 up 3.69%?

Dive Deeper

001060:KRX

JW Pharmaceutical Corp

₩25,300.00

+3.69%

(+900.00) 1D

Oct 16, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 001060...

Open

₩24,500

High

₩25,550

Low

₩24,500

Mkt. cap

607.55B

Avg. vol.

53.58K

Volume

0.00

Dividend

2.57%

Quarterly dividend

₩163

Ex-dividend date

Dec 27, 2023

P/E ratio

6.03

52-wk high

₩39,250

52-wk low

₩21,550

EPS

₩4,193

Shares outstanding

23.29M

No. of employees

Open

₩24,500

High

₩25,550

Low

₩24,500

Mkt. cap

607.55B

Avg. vol.

53.58K

Volume

0.00

Dividend

2.57%

Quarterly dividend

₩163

Ex-dividend date

Dec 27, 2023

P/E ratio

6.03

52-wk high

₩39,250

52-wk low

₩21,550

EPS

₩4,193

Shares outstanding

23.29M

No. of employees

Related stocks

Dong-A Socio Holdings Co Ltd

₩94,100.00

+3.86%

000250

Sam Chun Dang Pharm Co Ltd

₩204,500.00

+6.12%

001540

AHN-GOOK PHARMACEUTICAL Co Ltd

₩9,940.00

+2.79%

News stories

From web sources and news partners

Yahoo Finance

28 minutes ago

The 10-Year Treasury Is Above 5% for the First Time in Almost 20 Years. History Says This Is How the S&P 500 Index Will Perform Over the Next 12 Months.

Crypto Briefing

5 minutes ago

Morgan Stanley ties S&P 500 growth to a $1.6 trillion AI spending wave

www.tokenpost.com

2 hours ago

S&P 500 Health Care Sector Rises 3% as CVS Gains 7.2%

MarketWatch

1 hour ago

These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth

About JW Pharmaceutical Corp

CEOLee, Kyung Ha

Employees1.05K

Founded1945

Headquarters-

SectorPharmaceutical industry

Websitejw-pharma.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	200.02B	198.94B	199.88B	222.02B
Cost of goods sold	105.39B	109.09B	101.43B	116.73B
Cost of revenue	105.39B	109.09B	101.43B	116.73B
Research and development expenses	7.33B	15.27B	9.38B	11.86B
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	55.58B	60.42B	55.91B	59.90B
Operating expense	62.60B	80.98B	64.88B	71.95B
Total operating expenses	167.99B	190.07B	166.31B	188.68B
Operating income	32.03B	8.87B	33.58B	33.34B
Other non operating income	-4.64B	8.03B	1.21B	835.27M
EBT including unusual items	27.85B	17.49B	35.20B	34.76B
EBT excluding unusual items	27.85B	15.96B	35.20B	34.76B
Income tax expense	-2.74B	2.18B	7.72B	6.86B
Effective tax rate	-9.83%	12.44%	21.93%	19.75%
Other operating expenses	-	-	-	-
Net income	30.59B	15.32B	27.48B	27.89B
Net profit margin	15.29%	7.70%	13.75%	12.56%
Earnings per share	1.27K	-	-	-
Interest and investment income	-	3.34B	-	-
Interest expense	-	-4.42B	-	-
Net interest expenses	-	-1.09B	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	36.72B	13.65B	38.56B	38.37B
Gain or loss from assets sale	5.12M	3.00K	-10.00M	3.00K

Ask anything